Results 211 to 220 of about 172,321 (305)
Letter to the editor "Leiomyosarcoma of the inferior vena cava: case report". [PDF]
Aizaz MAR, Amin MHJ.
europepmc +1 more source
ABSTRACT Superior vena cava (SVC) syndrome is an uncommon complication of transvenous cardiac device leads. Diagnosis may be challenging due to gradually developing and nonspecific symptoms. Furthermore, anatomical imaging does not always reflect the hemodynamic significance of venous stenosis.
Fenna Daniëls +5 more
wiley +1 more source
Transjugular Left Atrial Appendage Occlusion in a Patient With Anomalous Inferior Vena Cava. [PDF]
Yap RL +9 more
europepmc +1 more source
Safety of Pulsed Field Ablation: Established Evidence, Emerging Risks, and Knowledge Gaps
Overview of the safety profile of pulsed field ablation (PFA), highlighting established safety advantages, procedure‐related complications, electroporation‐specific effects, and key areas of ongoing uncertainty, particularly for ventricular applications.
Dakota de Cecco +3 more
wiley +1 more source
Atrial Fibrillation Ablation Across an Inferior Vena Cava Filter. [PDF]
Beladel W +4 more
europepmc +1 more source
Understanding exosomes in facial esthetics and skin aging
Abstract Background Skin aging is a multifactorial process mediated by intrinsic (genetic and metabolic) and extrinsic (environmental) factors leading to functional and structural deterioration, including wrinkles, loss of collagen and elastin, as well as various pigmentation disorders.
Richard J. Miron +3 more
wiley +1 more source
Concurrent inferior vena cava syndrome and spontaneous retroperitoneal hemorrhage secondary to inferior vena cava filter thrombosis, treated with large bore mechanical thrombectomy: a case report. [PDF]
Khan BZ, Wigham A, Kearns D.
europepmc +1 more source
Inferior Vena Cava Filter Fracture Presenting as Deep Vein Thrombosis. [PDF]
Shigemoto K +6 more
europepmc +1 more source
ABSTRACT Gilvetmab is a caninised monoclonal antibody against canine PD‐1. Concurrent or sequential administration of anti‐PD‐1 antibodies and radiation therapy (RT) improves survival time in various species. Eighteen dogs with mast cell tumours (MCTs) were prospectively treated with 24 Gy of RT over Days 0, 7 and 21 and gilvetmab every 2 weeks ...
Tiffany W. Martin +2 more
wiley +1 more source

